| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies
|
Ranieri, G.
|
|
2013
|
88 |
1 |
p. 187-197
11 p.
|
article
|
| 2 |
Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis—A systematic review and meta-analysis
|
Theurich, Sebastian
|
|
2013
|
88 |
1 |
p. 178-186
9 p.
|
article
|
| 3 |
Biomolecular markers of cancer-associated thromboembolism
|
Hanna, Diana L.
|
|
2013
|
88 |
1 |
p. 19-29
11 p.
|
article
|
| 4 |
Cancer in developing countries: The next most preventable pandemic. The global problem of cancer
|
López-Gómez, Miriam
|
|
2013
|
88 |
1 |
p. 117-122
6 p.
|
article
|
| 5 |
CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma
|
Veillette, André
|
|
2013
|
88 |
1 |
p. 168-177
10 p.
|
article
|
| 6 |
Current status and future directions in induction chemotherapy for head and neck cancer
|
Argiris, Athanassios
|
|
2013
|
88 |
1 |
p. 57-74
18 p.
|
article
|
| 7 |
Design of oncology clinical trials: A review
|
Ananthakrishnan, Revathi
|
|
2013
|
88 |
1 |
p. 144-153
10 p.
|
article
|
| 8 |
Editorial Board
|
|
|
2013
|
88 |
1 |
p. CO2-
1 p.
|
article
|
| 9 |
Energy management – a critical role in cancer induction?
|
Garland, J.
|
|
2013
|
88 |
1 |
p. 198-217
20 p.
|
article
|
| 10 |
Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: A review of pharmacologic and clinical differences and applications in patients with cancer
|
Walenga, Jeanine M.
|
|
2013
|
88 |
1 |
p. 1-18
18 p.
|
article
|
| 11 |
HER2 status for prognosis and prediction of treatment efficacy in adenocarcinomas: A review
|
Thibault, Constance
|
|
2013
|
88 |
1 |
p. 123-133
11 p.
|
article
|
| 12 |
Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia
|
Koppelmans, Vincent
|
|
2013
|
88 |
1 |
p. 87-101
15 p.
|
article
|
| 13 |
Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysis
|
Diaz-Padilla, Ivan
|
|
2013
|
88 |
1 |
p. 154-167
14 p.
|
article
|
| 14 |
mTOR inhibitors in advanced renal cell carcinomas: From biology to clinical practice
|
Barthélémy, Philippe
|
|
2013
|
88 |
1 |
p. 42-56
15 p.
|
article
|
| 15 |
Risk of hematologic toxicities in patients with solid tumors treated with everolimus: A systematic review and meta-analysis
|
Funakoshi, Tomohiro
|
|
2013
|
88 |
1 |
p. 30-41
12 p.
|
article
|
| 16 |
State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: A literature review
|
Berardi, Rossana
|
|
2013
|
88 |
1 |
p. 75-86
12 p.
|
article
|
| 17 |
Supportive care needs of hematological cancer survivors: A critical review of the literature
|
Hall, Alix
|
|
2013
|
88 |
1 |
p. 102-116
15 p.
|
article
|
| 18 |
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
|
Guthrie, Graeme J.K.
|
|
2013
|
88 |
1 |
p. 218-230
13 p.
|
article
|
| 19 |
Tu-be or not tu-be: That is the question… About serous ovarian carcinogenesis
|
Chene, G.
|
|
2013
|
88 |
1 |
p. 134-143
10 p.
|
article
|
Journal description